Evidence map›Paper›PMID 29976881›Full record

ReviewToxins2018

Overview on the Mycotoxins Incidence in Serbia in the Period 2004⁻2016.

Bozidar Udovicki, Kris Audenaert, Sarah De Saeger, Andreja Rajkovic

Abstract readReview
In one paragraph

Review in Toxins, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Non-AflatoxigenicACS omega · 2023
    Article
  13. Changes inFoods (Basel, Switzerland) · 2022
    Article
  14. Review
  15. Molecules (Basel, Switzerland) · 2022
    Article
  16. Assessment ofToxins · 2022
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bozidar UdovickiFaculty of Agriculture, Department of Food Safety and Food Quality Management, University of Belgrade, Nemanjina 6, 11080 Zemun-Belgrade, Serbia. bozidar.udovicki@agrif.bg.ac.rs.ORCID 0000-0002-8780-0021
Kris AudenaertFaculty of Bioscience Engineering, Department of Plants and Crops, Ghent University Campus Schoonmeersen, Valentin Vaerwyckweg 1, B-9000 Ghent, Belgium. kris.audenaert@ugent.be.ORCID 0000-0002-8791-1282
Sarah De SaegerFaculty of Pharmaceutical Sciences, Department of Bioanalysis, Laboratory of Food Analysis, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium. Sarah.DeSaeger@UGent.be.ORCID 0000-0002-2160-7253
Andreja RajkovicFaculty of Agriculture, Department of Food Safety and Food Quality Management, University of Belgrade, Nemanjina 6, 11080 Zemun-Belgrade, Serbia. Andreja.Rajkovic@UGent.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With an average annual production of 6.9 M tonnes and 2.5 M tonnes of maize and wheat respectively, Serbia is one of the main grain producers and exporters in Europe. Cereals are also the major staple food in Serbian diet. In view of the high cereal consumption, for human and animal nutrition, the presence of mycotoxins entails a high public health risk of chronic exposure to mycotoxins. This study provides an overview of the incidence of predominant mycotoxins, mainly in cereal and dairy products, in Serbia, in the 2004⁻2016, using data reported in the scientific literature. The study demonstrated that the total prevalence of aflatoxins was 62.9% (

Indexed as

Animal FeedAnimalsEnvironmental MonitoringFood ContaminationHumansMycotoxinsSerbiaMycotoxinscerealsclimatedairy productsincidencemycotoxinsrisk assessment

Identifiers

PMID29976881
PMCPMC6070786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.